Loading…
Atossa Therapeutics, Inc. is projected to rise to $3.30 by 2027, a +39% move from its current price of $2.37. ATOS is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $2.27 | $2.37 | $2.48 | +0.01% |
| Jul 15 | $2.22 | $2.37 | $2.53 | +0.01% |
| Jul 16 | $2.19 | $2.37 | $2.56 | +0.02% |
| Jul 17 | $2.17 | $2.37 | $2.60 | +0.03% |
| Jul 18 | $2.14 | $2.37 | $2.62 | +0.03% |
| Jul 19 | $2.12 | $2.37 | $2.65 | +0.04% |
| Jul 20 | $2.10 | $2.37 | $2.67 | +0.05% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.10 | $2.37 | $2.67 | +0.05% |
| Week 2 | $2.00 | $2.37 | $2.81 | +0.09% |
| Week 3 | $1.93 | $2.37 | $2.92 | +0.14% |
| Week 4 | $1.87 | $2.37 | $3.02 | +0.18% |
| Week 5 | $1.82 | $2.38 | $3.11 | +0.23% |
| Week 6 | $1.77 | $2.38 | $3.19 | +0.27% |
| Week 7 | $1.73 | $2.38 | $3.26 | +0.32% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing medicines in areas of significant unmet medical need in oncology in the United States. Its lead drug candidate is oral (Z)-endoxifen, a selective estrogen receptor modulator and selective estrogen receptor degrader currently in Phase 2 clinical development for the treatment and reduction of risk of breast cancer, as well as in other therapeutic areas.
The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is based in Seattle, Washington.
Atossa Therapeutics, Inc. trades as ATOS and is currently priced at $2.49. It ranks 4,841st by market capitalization and has a market cap of $24.84M.
The forecast outlook shows a path of rising averages from 2026 onward, with the 2026 avg at $2.49 and a long-run trajectory toward higher levels by 2050 (avg $12.55). Max forecasts rise to $28.86 in 2050, reflecting bullish momentum in the later years.
The 2027–2050 stretch carries bullish sentiment with progressively higher averages and max values across years, indicating a gradual ascent in value over the long term.
A major floor 26.2% below — a decisive break under it would weaken the trend.
The nearest floor, 26.2% below — buyers have tended to step in here.
The nearest ceiling, 120.7% above — a clean break opens room to run.
A major ceiling 178.3% above — clearing it would confirm fresh momentum.
Key ATOS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ATOS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.39 | Sell | $2.34 | Buy |
| MA 10 | $2.19 | Buy | $2.29 | Buy |
| MA 20 | $2.14 | Buy | $2.54 | Sell |
| MA 50 | $3.90 | Sell | $3.52 | Sell |
| MA 100 | $4.47 | Sell | $4.79 | Sell |
| MA 200 | $7.85 | Sell | $6.91 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 38.04 | Neutral |
| Stoch RSI (14) | 91.77 | Sell |
| CCI (20) | 66.42 | Neutral |
| Williams %R (14) | -16.22 | Info |
| MACD (12,26,9) | 0.16 | Buy |
| ROC (12) | 24.74 | Buy |
| Bollinger %B (20,2) | 0.72 | Neutral |
| Stochastic %K (14) | 83.78 | Sell |
| TRIX (15) | -2.66 | Sell |
| Awesome (5,34) | -0.86 | Sell |
| Ultimate (7,14,28) | 67.68 | Neutral |
| Momentum (10) | 0.60 | Buy |
| Aroon Osc (25) | -52.00 | Sell |
| Hull MA (9) | 2.51 | Sell |
| ADX (14) | 39.48 | Sell |
| ATR (14) | 0.14 | Info |
The 30-day technical picture is NEUTRAL.
RSI14 is 40, the SMA50 is $4.09, and the SMA200 is $8.01. Key support stands at $1.75 with a resistance at $5.23. The observed 30-day price range runs from a low of $1.80 to a high of $3.44.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.75 | $2.37 | $3.72 | 0% | Neutral | |
| $2.46 | $3.30 | $4.75 | +39% | Bullish | |
| $2.69 | $3.79 | $5.77 | +60% | Bullish | |
| $2.30 | $3.38 | $5.37 | +43% | Bullish | |
| $2.15 | $3.27 | $5.39 | +38% | Bullish | |
| $2.35 | $3.71 | $6.30 | +56% | Bullish | |
| $2.05 | $3.34 | $5.84 | +41% | Bullish | |
| $2.57 | $4.32 | $7.75 | +82% | Bullish | |
| $3.16 | $5.49 | $10.06 | +132% | Bullish | |
| $2.88 | $5.16 | $9.65 | +118% | Bullish | |
| $3.44 | $7.09 | $14.46 | +199% | Bullish | |
| $4.95 | $11.00 | $25.30 | +364% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $1.75 | $2.37 | $2.99 | +0.00% |
| August 2026 | $2.04 | $2.45 | $3.06 | +3.46% |
| September 2026 | $1.96 | $2.38 | $3.02 | -2.77% |
| October 2026 | $2.08 | $2.56 | $3.30 | +7.40% |
| November 2026 | $2.25 | $2.79 | $3.63 | +8.86% |
| December 2026 | $2.26 | $2.82 | $3.72 | +1.28% |
Click any year to see its month-by-month ATOS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, ATOS is projected to trade between $1.75 and $3.72, averaging $2.37 — a potential gain of 0% from today's $2.37. Price action looks broadly range-bound.
Atossa Therapeutics, Inc.'s 2027 outlook centres on $3.30, within a $2.46 to $4.75 range. That is up +39% on the projected 2026 average. That marks a +39% change versus current levels. Buyers look set to stay in control over this stretch.
By 2028, ATOS could reach as high as $5.77, with a base case around $3.79 and support toward $2.69 — roughly +60% from $2.37. Momentum favours further upside here.
Expect ATOS to range from $2.30 to $5.37 through 2029. The $3.38 average target implies a +43% move from current prices. That is -11% versus the projected 2028 average. Buyers look set to stay in control over this stretch.
The ATOS price prediction for 2030 points to an average of $3.27 (low $2.15, high $5.39) — a potential gain of +38% on today's $2.37. Momentum favours further upside here.
In 2031, ATOS is projected to trade between $2.35 and $6.30, averaging $3.71 — a potential gain of +56% from today's $2.37. That is up +13% on the projected 2030 average. Buyers look set to stay in control over this stretch.
Atossa Therapeutics, Inc.'s 2032 outlook centres on $3.34, within a $2.05 to $5.84 range. That is -10% versus the projected 2031 average. That marks a +41% change versus current levels. Momentum favours further upside here.
By 2033, ATOS could reach as high as $7.75, with a base case around $4.32 and support toward $2.57 — roughly +82% from $2.37. Buyers look set to stay in control over this stretch.
Expect ATOS to range from $3.16 to $10.06 through 2034. The $5.49 average target implies a +132% move from current prices. That is up +27% on the projected 2033 average. Momentum favours further upside here.
The ATOS price prediction for 2035 points to an average of $5.16 (low $2.88, high $9.65) — a potential gain of +118% on today's $2.37. Buyers look set to stay in control over this stretch.
In 2040, ATOS is projected to trade between $3.44 and $14.46, averaging $7.09 — a potential gain of +199% from today's $2.37. That is up +38% on the projected 2035 average. Momentum favours further upside here.
Atossa Therapeutics, Inc.'s 2050 outlook centres on $11.00, within a $4.95 to $25.30 range. That is up +55% on the projected 2040 average. That marks a +364% change versus current levels. Buyers look set to stay in control over this stretch.
Investing $1,000 in ATOS today (≈ 421.940928 ATOS) could be worth
$4,640.49
+$3,640.49 (+364%) by 2050 · US Dollar
Based on the average projected ATOS price of $11 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ATOSwould be worth at today's price.
$1,000 invested in ATOS on Jul 10, 2025 (≈ 74.906365 ATOS) would be worth
$177.53
-$822.47 (-82.2%) today · 0.18× · US Dollar
Based on a ATOS entry price of $13.35 vs. today's $2.37.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.12 | $1,117.92 | +11.8% |
| 1 month ago | $4.4 | $538.64 | -46.1% |
| 3 months ago | $4.94 | $479.76 | -52.0% |
| 6 months ago | $9.75 | $243.08 | -75.7% |
| 1 year ago | $13.35 | $177.53 | -82.2% |
| All time (5.0y) ago | $95.25 | $24.88 | -97.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ATOS forecast.
Our base-case forecast reaches $4.70 around 2034.
Implied market cap at $4.70: $46.88M
For 2026 the forecast lists min $1.75, avg $2.49, max $4.04, ROI 0, sentiment NEUTRAL.
In 2027 the forecast shows min $2.64, avg $3.58, max $5.25, ROI 43.9, sentiment BULLISH. In 2028 the forecast shows min $2.86, avg $4.10, max $6.38, ROI 64.8, sentiment BULLISH.
In 2029 the forecast shows min $2.41, avg $3.62, max $5.89, ROI 45.5, sentiment BULLISH. In 2030 the forecast shows min $2.26, avg $3.55, max $5.99, ROI 42.5, sentiment BULLISH.
From 2033 onward the forecast remains bullish with 2033 min $2.82, avg $4.93, max $9.10, ROI 98.1, sentiment BULLISH; 2034 min $3.45, avg $6.26, max $11.82, ROI 151.3, sentiment BULLISH; 2035 min $3.06, avg $5.74, max $11.09, ROI 130.7, sentiment BULLISH. By 2040 the forecast shows min $3.73, avg $8.22, max $17.36, ROI 230.3, sentiment BULLISH, and by 2050 min $5.65, avg $12.55, max $28.86, ROI 403.9, sentiment BULLISH.
Tap a question to reveal the answer.
The 2030 forecast lists min $2.26, avg $3.55, max $5.99, ROI 42.5, sentiment BULLISH.
Forecasts show bullish sentiment from 2027 onward with rising averages toward $12.55 by 2050 and a max of $28.86; however, these are estimates, not guarantees.
Yes, the forecast max reaches $11.09 in 2035, $17.36 in 2040, and $28.86 in 2050.
Current price $2.49 and market cap $24.84M.
The 30-day range is $1.80 to $3.44.
Atossa Therapeutics, Inc. Community Discussion
0Share your Atossa Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.